Plus   Neg

Pacific Biosciences Of California (PACB) Is Up After Bought By Illumina

Pacific Biosciences of California (PACB) announced after the bell Thursday that it has agreed to be acquired by Illumina (ILMN) for $8.00 per share in cash.

Pacific Biosciences of California has gapped open sharply higher Friday morning and is now up 3.02 at $7.53. The stock has leaped to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT